Skip to main content
GeneOne Life Science, Inc. logo

GeneOne Life Science, Inc. — Investor Relations & Filings

Ticker · 011000 ISIN · KR7011000007 KO Professional, scientific and technical activities
Open in API
Filings indexed 490 across all filing types
Latest filing 2026-02-13 Major Shareholding Noti…
Country KR South Korea
Listing KO 011000

About GeneOne Life Science, Inc.

https://www.genels.com/en/

GeneOne Life Science, Inc. is a biopharmaceutical research and development company specializing in nucleic acid-based biomedicines. The company's core focus is on developing DNA and mRNA vaccines, particularly for emerging infectious diseases, leveraging its rapid development platforms. In therapeutics, GeneOne utilizes a proprietary DNA plasmid delivery technology to enable the expression of recombinant proteins and plasmid-encoded monoclonal antibodies (Plas-mAbs®). This non-viral vector approach is designed to offer a safer and more cost-effective alternative to traditional gene therapies and cell-line derived monoclonal antibody treatments for conditions such as cancers and autoimmune disorders. The company also develops immunomodulatory small molecule drugs. Through its subsidiary, GeneOne possesses cGMP-grade manufacturing capabilities for DNA plasmids, supporting its internal pipeline and contract manufacturing services.

Recent filings

Filing Released Lang Actions
[기재정정]주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership by a major shareholder (Park Young Kun) in Jinon Life Sciences. This falls under the 'Major Shareholding Notification' category as it tracks significant changes in ownership levels.
2026-02-13 Korean
최대주주등소유주식변동신고서(최대주주변경시)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by GeneOne Life Science. This document details changes in share ownership, including the acquisition and disposal of shares by major shareholders and executives, and the resulting change in the major shareholder status. In the context of financial filings, this is a standard regulatory disclosure regarding significant shareholding changes, which falls under the 'Major Shareholding Notification' category.
2026-02-13 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the amendment (정정신고) of a previous capital increase filing, specifically updating the payment date, share issuance date, and listing date. This type of regulatory filing in the Korean market (DART system) is classified as a capital/financing update as it pertains to the company's capital structure and fundraising activities.
2026-02-09 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Park Young Kun) in Jinwon Life Sciences. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels.
2026-02-06 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) which is a regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership, specifically reporting a reduction in holdings and a change in the purpose of holding from 'management influence' to 'simple investment' due to the resignation of the reporter from executive positions. This falls under the category of Major Shareholding Notification.
2026-02-06 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a regulatory filing in South Korea used to disclose significant changes in share ownership (often referred to as the 5% rule). The document explicitly details changes in shareholding percentages, the identity of the major shareholder, and the purpose of the holding (changing from management influence to simple investment). This falls under the 'Major Shareholding Notification' category.
2026-02-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.